- American City Business Journals•2 days ago
Dan Santi could have taken his biotech startup, which has an innovative technology for keeping drugs in the body longer, anywhere in the Bay Area. Over the past five years in the CoLaborator incubator inside Bayer AG's Mission Bay outpost, Santi’s ProLynx LLC struck collaborations with Bayer and other drug companies that set the stage for taking its first drug into human clinical trials.
- The Wall Street Journal•3 days ago
Fusion Pharmaceuticals Inc. has raised $25 million in a bid to build on the success of a new radio-pharmaceutical from Bayer AG that extends life for certain prostate cancer patients.
- GuruFocus.com•3 days ago
The Monsanto and Syngenta buyouts offer attractive returns
BAYRY : Summary for BAYER AG SPON ADR REP 1 NPV - Yahoo Finance
Bayer Aktiengesellschaft (BAYRY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||110.15 - 110.74|
|52 Week Range||91.53 - 125.20|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||18.30|
|Dividend & Yield||2.87 (2.59%)|
|1y Target Est||N/A|